Advisory Research’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $852K | Buy |
10,277
+691
| +7% | +$57.3K | 0.13% | 110 |
|
|
2025
Q1 | $777K | Buy |
9,586
+26
| +0.3% | +$2.11K | 0.14% | 116 |
|
|
2024
Q4 | $861K | Buy |
9,560
+51
| +0.5% | +$4.59K | 0.14% | 117 |
|
|
2024
Q3 | $939K | Sell |
9,509
-321
| -3% | -$31.7K | 0.17% | 110 |
|
|
2024
Q2 | $911K | Buy |
9,830
+648
| +7% | +$60.1K | 0.17% | 109 |
|
|
2024
Q1 | $871K | Sell |
9,182
-562
| -6% | -$53.3K | 0.17% | 107 |
|
|
2023
Q4 | $870K | Sell |
9,744
-526
| -5% | -$47K | 0.13% | 178 |
|
|
2023
Q3 | $750K | Sell |
10,270
-779
| -7% | -$56.9K | 0.1% | 224 |
|
|
2023
Q2 | $919K | Buy |
11,049
+3,244
| +42% | +$270K | 0.12% | 214 |
|
|
2023
Q1 | $595K | Sell |
7,805
-148
| -2% | -$11.3K | 0.1% | 227 |
|
|
2022
Q4 | $660K | Sell |
7,953
-8
| -0.1% | -$664 | 0.06% | 216 |
|
|
2022
Q3 | $631K | Buy |
+7,961
| New | +$631K | 0.06% | 211 |
|